Web Date: August 24, 2017
Viruslike nanoparticles kill drug-resistant bacteria
Viruslike polymer nanoparticles can target and kill different types of bacteria—including antibiotic-resistant strains—while sparing human cells, according to a new study (ACS Infect. Dis. 2017, DOI: 10.1021/acsinfecdis.7b00076). What’s more, fine-tuning the size and shape of these fuzzy polymer nanoparticles alters their potency. The strategy could represent a step towards a new class of antimicrobials that could fight infections while avoiding antibiotic resistance.
The rise . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society